| 705 - 714 |
Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres
Fu X, Ping Q, Gao Y |
| 715 - 735 |
Microencapsulation of higher hydrocarbon phase change materials by in situ polymerization
Boh B, Knez E, Staresinic M |
| 737 - 744 |
Mucosal delivery of cytotoxic therapeutic agents: Response of rat nasal mucosa to microencapsulated ethopropazine HCl enantiomer
Persyn JT, McDonough JA, Nino JA, Dixon H, Boland EJ |
| 745 - 759 |
Monodisperse structured multi-vesicle microencapsulation using flow-focusing and controlled disturbance
Bocanegra R, Sampedro JL, Ganan-Calvo AM, Marquez M |
| 761 - 771 |
Effects of divalent cations on drug encapsulation efficiency of deacylated gellan gum
Singh BN, Kim KH |
| 773 - 785 |
Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol
Budhian A, Siegel SJ, Winey KI |
| 787 - 792 |
Viability analysis of alginate encapsulated micro-organisms using fluorescent stains
Pereira T, Millar TJ, Chuck JA |
| 793 - 808 |
PEG-derivative effectively modifies the characteristics of indomethacin-PLGA microspheres destined to intra-articular administration
Puebla P, Pastoriza P, Barcia E, Fernandez-Carballido A |
